Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study
CMAB008 与创新药英夫利昔单抗在接受甲氨蝶呤联合治疗的中重度类风湿关节炎患者中的疗效和安全性比较:一项随机、双盲、多中心、III期非劣效性研究
期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00544-2
Ye, Hua; Liu, Shengyun; Xu, Jian; Chai, Kexia; He, Dongyi; Fang, Yongfei; Xie, Qibing; Liu, Huaxiang; Liu, Ying; Hua, Bingzhu; Hu, Jiankang; Zhang, Zhiyi; Zhou, Mingxuan; Zhao, Dongbao; Li, Yan; Jiang, Zhenyu; Wang, Meimei; Li, Jingyang; Zhang, Zhuoli; Li, Xiaomei; Li, Yang; Sun, Erwei; Bi, Liqi; Wei, Wei; Tie, Ning; He, Lan; Huang, Xiangyang; Zhang, Yan; Huang, Qingchun; Wang, Xiaofei; Liu, Xiangyuan; Li, Jing; Su, Yin